Literature DB >> 6657912

Wegener's granulomatosis: observations on 18 patients with severe renal disease.

A J Pinching, C M Lockwood, B A Pussell, A J Rees, P Sweny, D J Evans, N Bowley, D K Peters.   

Abstract

Eighteen patients with Wegener's granulomatosis with renal involvement have been studied. Their course before treatment has indicated how the disease may progress and has provided a framework for diagnosis based on clinical and radiological features combined with available histology. The need for such diagnostic criteria is emphasised by the fact that a firm histopathological diagnosis could only be made in nine patients. A strong association between Wegener's granulomatosis and previous suppurative or tuberculous respiratory infection has been noted as well as between intercurrent infection and relapse. Evidence that immune complexes play a pathogenetic role has come from the association between active disease and circulating immune complexes. The observation of a reversible abnormality of splenic clearance of altered red cells suggests that immune complex handling by the spleen is defective. Treatment of these patients has shown a surprising degree of reversibility in many manifestations, especially renal failure. Remissions occurring spontaneously or induced by steroids alone are temporary and steroids, if used alone, may adversely affect outcome. While confirming the central role of cyclophosphamide in the induction of remission, this study has indicated that its combination with steroids and/or plasma exchange may be valuable in initial control of fulminating disease. The fact that seven patients died during induction (as well as a further four in the succeeding five years) reflects the advanced disease at presentation and the infective problems associated with immunosuppressive therapy. This highlights the need for earlier diagnosis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6657912

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  43 in total

1.  Chronic bronchial suppuration and antineutrophil cytoplasmic antibody (ANCA) positive systemic vasculitis.

Authors:  D Sitara; B I Hoffbrand
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

2.  Limited Wegener's granulomatosis--is it limited?

Authors:  Svetlana Lisitsin; Raymond Farah; Moshe Shay
Journal:  Clin Rheumatol       Date:  2007-03-31       Impact factor: 2.980

3.  Detection of anti-myeloperoxidase and anti-elastase antibodies in vasculitides and infections.

Authors:  M C Gallicchio; J A Savige
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

Review 4.  ANCA-associated diseases and silica exposure.

Authors:  G Gregorini; P Tira; J Frizza; P C D'Haese; M M Elseviers; G Nuyts; R Maiorca; M E De Broe
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

5.  Microscopic polyarteritis: clinical features and treatment.

Authors:  H Rodgers; J A Guthrie; A M Brownjohn; J H Turney
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

6.  Granulomatous gastritis in Wegener's disease: differentiation from Crohn's disease supported by a positive test for antineutrophil antibodies.

Authors:  B Temmesfeld-Wollbrueck; C Heinrichs; A Szalay; W Seeger
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

Review 7.  Granulomatosis with polyangiitis (Wegener's disease): An updated review of ocular disease manifestations.

Authors:  Buraa Kubaisi; Khawla Abu Samra; C Stephen Foster
Journal:  Intractable Rare Dis Res       Date:  2016-05

Review 8.  Vasculitis in childhood.

Authors:  I Roberti; L Reisman; J Churg
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

9.  Anti-proteinase 3 antibodies, their characterization and disease associations.

Authors:  J G Jennings; L Chang; J A Savige
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

10.  Cardiac involvement in Wegener's granulomatosis.

Authors:  N E Goodfield; S Bhandari; W D Plant; A Morley-Davies; G R Sutherland
Journal:  Br Heart J       Date:  1995-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.